Answer:
A. Chemical modification may allow for extended drug capacities such as expanded spectrum of activity and increased stability.
Explanation:
Any modification in antibiotic structure and chemical will affects its ability in a way to increase it capability of target microbes and act efficiently. These modification can increase half life and stability of the drug.
The answer will be Goddess
Answer:
DNA → mRNA → tRNA → Protein
DNA → mRNA → tRNA → Protein
Explanation:
This is because during protein synthesis, DNA is use to make RNA in the process called transcription. The DNA double strand is unwind by an enzyme called RNA polymerase to produce mRNA in the nucleus. The trans is produced in the nucleolus by RNA polymerase 1 and the site then binds aminoacyl tRNAs which is assembled in the RIBOSOMES. The tRNA are then translated into protein.
<u>Answer:</u>
The series dilution method is the step wise dilution technique where the dilution factors remain constant in each step.
The advantages of using the series of dilution method over simple dilution are stated below:
<em>a) Aids in reduction of a dense culture of cells to a more usable concentration.</em>
<em>b) In every step of dilution the specific amount of bacteria is removed. </em>
<em>c) Helps in the estimation of concentration of an unknown sample.</em>
<em>This sums up the advantage of using the series dilution technique.</em>
Answer:
Thermosensitive liposomes (TSL) are promising tools used to deliver drugs to targeted region when local hyperthermia is applied (∼40–42°C) which triggers the membrane phase transformation from a solid gel-like state to a highly permeable liquid state. Selective lipid components have been used to in TSL formulations to increase plasma stability before hyperthermia and speed drug release rate after. Two generations of TSL technology have been developed. The traditional thermal sensitive liposomes (TTSL) have utilized DPPC and DSPC as a combination. The second generation, lysolipid thermally sensitive liposomes (LTSL) technology, has been developed with incorporation of lysolipids that form stabilized defects at phase transition temperature. LTSL maintains certain favorable attributes:
High percentage of lysolipids incorporation;
Minimum leakage for therapeutical drugs encapsulation;
Ultrafast drug release upon heating (3.5 times enhanced compared to TTSL). For example, ThermoDox, a commonly used LTSL drug for cancer, has been reported to release 100% of the encapsulated doxorubicin within 30s;
First and most successful formulation for intravascular drug release.
Explanation:
https://www.creative-biostructure.com/Lysolipid-Thermally-Sensitive-Liposomes-Production-612.htm
